Request for Expressions of Interest: Interchangeable Drug Formulary Advisory Committee
The Department of Health and Community Services is seeking a candidate for appointment to the Newfoundland and Labrador Prescription Drug Program Interchangeable Drug Products Formulary Advisory Committee established pursuant to Section 20 of the Pharmaceutical Services Act (Act). The purpose of the Advisory Committee is to advise on the contents of the formulary and other matters relating to drugs such as reviewing drug submissions for consideration of interchangeability between generic drug products and the innovator products, and making recommendations on the methods of establishing NIDPF published prices.
If you are interested in participating on the Advisory Committee, please submit an expression of interest and your CV by end of day March 14, 2024. The NLMA will forward the list of candidates to the Minister of Health.